Clinical Significance of TdT, Cell Surface Markers and CFU-C in 297 Patients with Hematopoietic Neoplasias
- 1 January 1979
- book chapter
- Published by Springer Nature
- Vol. 23, 131-138
- https://doi.org/10.1007/978-3-642-67057-2_16
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Improved biochemical assay for terminal deoxynucleotidyl transferase in human blood cells: Results in 89 adult patients with lymphoid leukemias and malignant lymphomas in leukemic phaseLeukemia Research, 1978
- Terminal deoxynucleotidyl transferase in the diagnosis of leukemia and malignant lymphomaThe American Journal of Medicine, 1978
- Pre-B-Cell LeukemiaNew England Journal of Medicine, 1978
- Terminal Transferase as a Predictor of Initial Responsiveness to Vincristine and Prednisone in Blastic Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1978
- A study of malignant lymphomas using light and ultramicroscopic, cytochemical and immunologic technics: Correlation with clinical featuresThe American Journal of Medicine, 1978
- Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cellsThe American Journal of Medicine, 1977
- Terminal Deoxynucleotidyl Transferase Activity in Malignant LymphomasNew England Journal of Medicine, 1977
- Terminal deoxynucleotidyltransferase distribution in neoplastic and hematopoietic cells.Journal of Clinical Investigation, 1977
- TARGET CELL IN CHRONIC MYELOID LEUKÆMIA AND ITS RELATIONSHIP TO ACUTE LYMPHOID LEUKÆMIAThe Lancet, 1976
- Immunological Classification of Acute Lymphoblastic Leukaemias: Evaluation of its Clinical Significance in a Hundred PatientsBritish Journal of Haematology, 1976